Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurora Zanghì

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Neural Regeneration Research|August 12, 2021
Injectable <i>versus</i> oral first-line multiple sclerosis therapies: knows and unknowns from observational studiesEmanuele D'Amico, Aurora Zanghì, Carlo Avolio
Expert Review of Neurotherapeutics|January 24, 2020
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatmentAurora Zanghì, Emanuele D'Amico, Francesco Patti
Expert Opinion on Pharmacotherapy|December 1, 2016
Can new chemical therapies improve the management of multiple sclerosis in children?Emanuele D'Amico, Aurora Zanghì, Francesco Patti
Expert Review of Neurotherapeutics|October 11, 2016
Palliative care in progressive multiple sclerosisEmanuele D'Amico, Aurora Zanghì, Francesco Patti, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World StudyAurora Zanghì, Emanuele D'Amico, Francesco Patti, et al.
International Journal of Molecular Sciences|October 21, 2016
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesEmanuele D'Amico, Francesco Patti, Aurora Zanghì, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: A prospective case-control studyEmanuele D'Amico, Aurora Zanghì, Aldo Eugenio Calogero, et al.
Therapeutic Advances in Chronic Disease|March 15, 2021
Exploring polypharmacy phenomenon in newly diagnosed relapsing-remitting multiple sclerosis: a cohort ambispective single-centre studyAurora Zanghì, Emanuele D'Amico, Salvatore Lo Fermo, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic ChallengesMaria Luca, Clara Grazia Chisari, Aurora Zanghì, et al.
Frontiers in Neurology|September 19, 2022
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implicationsAurora Zanghì, Carlo Avolio, Hans-Peter Hartung, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Neural Regeneration Research|August 12, 2021
Injectable <i>versus</i> oral first-line multiple sclerosis therapies: knows and unknowns from observational studiesEmanuele D'Amico, Aurora Zanghì, Carlo Avolio
Expert Review of Neurotherapeutics|January 24, 2020
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatmentAurora Zanghì, Emanuele D'Amico, Francesco Patti
Expert Opinion on Pharmacotherapy|December 1, 2016
Can new chemical therapies improve the management of multiple sclerosis in children?Emanuele D'Amico, Aurora Zanghì, Francesco Patti
Expert Review of Neurotherapeutics|October 11, 2016
Palliative care in progressive multiple sclerosisEmanuele D'Amico, Aurora Zanghì, Francesco Patti, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World StudyAurora Zanghì, Emanuele D'Amico, Francesco Patti, et al.
International Journal of Molecular Sciences|October 21, 2016
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future PerspectivesEmanuele D'Amico, Francesco Patti, Aurora Zanghì, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: A prospective case-control studyEmanuele D'Amico, Aurora Zanghì, Aldo Eugenio Calogero, et al.
Therapeutic Advances in Chronic Disease|March 15, 2021
Exploring polypharmacy phenomenon in newly diagnosed relapsing-remitting multiple sclerosis: a cohort ambispective single-centre studyAurora Zanghì, Emanuele D'Amico, Salvatore Lo Fermo, et al.
International Journal of Environmental Research and Public Health|June 2, 2021
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic ChallengesMaria Luca, Clara Grazia Chisari, Aurora Zanghì, et al.
Frontiers in Neurology|September 19, 2022
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implicationsAurora Zanghì, Carlo Avolio, Hans-Peter Hartung, et al.
Pageof 7